Warren Averett Asset Management, LLC Amgen Inc Transaction History

Warren Averett Asset Management, LLC

$5.34 Billion
Q3 2024

A detailed history of Warren Averett Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 26,311 shares of AMGN stock, worth $7.46 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

26,311

Previous 23,612 11.43%

Holding current value

$7.46 Million

Previous $7.38 Million 14.91%

% of portfolio

0.16%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $835,016 - $910,588	2,699 Added 11.43%	26,311 $8.48 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $3.67 Million - $4.47 Million	13,984 Added 145.24%	23,612 $7.38 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $912,275 - $1.1 Million	3,393 Added 54.42%	9,628 $2.74 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $75,942 - $85,672	-297 Reduced 4.55%	6,235 $1.8 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $195,035 - $242,142	892 Added 15.82%	6,532 $1.76 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $969,357 - $1.15 Million	4,524 Added 405.38%	5,640 $1.25 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $17,837 - $21,740	-79 Reduced 6.61%	1,116 $269,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $14,199 - $18,042	-62 Reduced 4.93%	1,195 $313,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $22,670 - $25,568	101 Added 8.74%	1,257 $283,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $11,766 - $13,093	51 Added 4.62%	1,156 $281,000
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $8,990 - $9,945	41 Added 3.85%	1,105 $267,000
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $52,504 - $60,086	-264 Reduced 19.88%	1,064 $243,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $42,029 - $49,242	198 Added 17.52%	1,328 $281,000
Q2 2021 Aug 17, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.09%	1,130 $260,000
Q1 2021 May 24, 2021	BUY	$221.91 - $258.6 $250,536 - $291,959	1,129 New	1,129 $284,000
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $203,441 - $226,243	-867 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$197.81 - $242.74 $171,501 - $210,455	867 New	867 $208,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $462,412 - $539,784	-2,592 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $20,011 - $22,560	108 Added 4.35%	2,592 $537,000
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $15,276 - $17,158	-92 Reduced 3.57%	2,484 $459,000
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $525,233 - $613,800	-3,100 Reduced 54.62%	2,576 $439,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $524,092 - $585,571	3,105 Added 120.77%	5,676 $987,000
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $430,102 - $491,061	2,571	2,571 $479,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Warren Averett Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warren Averett Asset Management, LLC with notifications on news.

Account

Warren Averett Asset Management, LLC Amgen Inc Transaction History